Document is current
Any future updates will be listed below
-
Authors
Jonasch, Eric http://orcid.org/0000-0003-0943-2806
Walker, Cheryl Lyn
Rathmell, W. Kimryn http://orcid.org/0000-0002-4984-0225
-
License Information
Text and Data Mining valid from 2020-11-03
Version of Record valid from 2020-11-03
-
More Information
Article History
Accepted: 22 September 2020
First Online: 3 November 2020
Competing interests
: E.J. has received research funding from Exelixis, Novartis, Peloton and Pfizer and consulting fees from Eisai, Exelixis, Genentech, Ipsen, Novartis, Peloton, Pfizer and Roche. The other authors declare no competing interests.
